Pharmaceutical formulation of cineol and amoxicillin

Abstract

The present invention relates to a pharmaceutical formulation in powder form comprising arnoxicillin, cineol and a pharmaceutically acceptable oil. The present formulation may further comprise clavulanic acid. It is intended for oral administration, preferably after suspension in an aqueous solvent. The present invention also relates to a combination of cineol and amoxicillin for use in the treatment of an infectious pathology, preferably a bacterial infection, in a subject. The present combination may further comprise an inhibitor of β-lactamases, preferably clavulanic acid. The combination according to the invention makes it possible in particular to combat infections caused by antibiotic-resistant bacteria, preferably antibiotics of the β-lactam family.